Affiliation:
1. Department of Endocrine Neoplasia and Hormonal Disorders, The University of Texas MD Anderson Cancer, Houston, Texas.
Abstract
SummaryRadioactive iodine (RAI) treatment is an effective treatment for differentiated thyroid cancer (DTC); however, many patients are refractory. Using targeted drugs to reinduce RAI sensitivity (“redifferentiation therapy”) has long been sought after as the holy grail in endocrine oncology.See related article by Weber et al., p. 4194
Publisher
American Association for Cancer Research (AACR)
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献